Global Surface Guided Radiation Therapy Devices Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Surface Guided Radiation Therapy Devices Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Surface guided radiation therapy devices are the medical radiation devices that are utilized for the SGRT. The technology positions and monitors the patient's surface radiation process on the external surface such that the patient's positioning is apt. This procedure provides transitional and rotational information on the patient's skin surface and offers the potential to improve the accuracy of setup. The clinical use of surface imaging has increased dramatically, with demonstrated utility for initial patient positioning, real-time motion monitoring, and beam gating in a variety of anatomical sites.

Market Overview:

The latest research study on the global Surface Guided Radiation Therapy Devices market finds that the global Surface Guided Radiation Therapy Devices market reached a value of USD 172.58 million in 2023. It’s expected that the market will achieve USD 424.03 million by 2029, exhibiting a CAGR of 16.16% during the forecast period.

Surface Guided Radiation Therapy Devices Market Drivers Analysis

The primary drivers driving the surface guided radiation therapy market are the increased prevalence of malignant growth and growing demand for cutting-edge therapies, rising cancer incidences and quick advancements in disease treatment, and high morbidity and death rates globally. The expansion of human services, government support for research and development, and increased demand for better cancer treatment all contribute to the growth of the surface guided radiation therapy market. The high utilization of therapy in pre-treatment and treatment stimulates an activity that can improve or check radiotherapy precision, an increase in the number of research and development activities, and an increase in demand for sophisticated therapies all have an impact on the surface guided radiation therapy market.

Surface Guided Radiation Therapy Devices Market Challenges Analysis

While SGRT is becoming part of clinical practice, its implementation has been challenging due to lack of guidelines and resources (i.e., time, staff, money) particularly since the clinical value of SGRT has not been unequivocally established and its clinical use is typically not reimbursed. The main concerns regarding SGRT use include the system integration and performance, costs or future costs for additional systems, and the absence of guidelines and optimization protocols. Other concerns include extending SGRT to other sites, lack of demonstrated clinical value, and staff training. As conflicts in system integration and performance were the major challenges seen by the survey participants, SGRT vendors should make continuous effort to improve these aspects of their systems.

Region Overview:

In 2022, the share of the Surface Guided Radiation Therapy Devices market in United States stood at 36.22%.

Company Overview:

Vision RT Ltd
Vision RT was founded in 2001 with a mission to develop pioneering technology for Surface Guided Radiation Therapy (SGRT), with the goal of enabling patient comfort and enhancing treatment efficacy and efficiency.

C-Rad AB

C-RAD is a medical technology company that produces surface guided radiation therapy (SGRT) solutions to increase treatment accuracy and patient safety in the entire radiation therapy workflow.

Vision RT Ltd is one of the major players operating in the Surface Guided Radiation Therapy Devices market, holding a share of 47.38% in 2023.

Segmentation Overview:

Among different product types, Stereovision segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Breast Cancer segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Surface Guided Radiation Therapy Devices market covered in Chapter 3:

C-Rad AB
Vision RT Ltd
BrainLab AG
Klarity Medical
Varian Medical Systems, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Surface Guided Radiation Therapy Devices market from 2019 to 2030 is primarily split into:

Stereovision
Structured Light Imaging

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Surface Guided Radiation Therapy Devices market from 2019 to 2030 covers:

Breast Cancer
Head & Neck Cancer
Abdominal & Pelvic Cancer
Lung Cancer
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)